Search

Displaying results 7761 - 7770 of 8696 in total
  1. Drug

    Acefylline

    go.drugbank.com/drugs/DB13573
    Experimental

    Categories: Drugs for Obstructive Airway Diseases, Cytochrome P-450 Substrates
  2. Drug

    Tiropramide

    go.drugbank.com/drugs/DB13091
    Investigational

    Tiropramide is under investigation in clinical trial NCT01629212 (Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome).

    Categories: Drugs for Functional Gastrointestinal Disorders
  3. Drug

    Butyrylcholinesterase

    go.drugbank.com/drugs/DB06352
    Investigational

  4. Drug

    L-cysteic acid

    go.drugbank.com/drugs/DB03661
    Experimental

    It is an amino acid with a C-terminal sulfonic acid group which has been isolated from human hair oxidized with permanganate.

  5. Drug

    Cyamemazine

    go.drugbank.com/drugs/DB09000
    Experimental

    Cyamemazine actually behaves like an atypical antipsychotic, due to its potent anxiolytic effects (5-HT2C) and lack of extrapyramidal side effects (5-HT2A).

    Categories: Serotonin Receptor Antagonists, Serotonin 5-HT1 Receptor Antagonists
  6. Drug

    Nisoxetine

    go.drugbank.com/drugs/DB09186
    Experimental

    It was originally investigated as an antidepressant but has no current clinical applications aside from being a research standard SNRI.

  7. Drug

    Luveltamab tazevibulin

    go.drugbank.com/drugs/DB17563
    Investigational

    [A257414] It is under investigation in clinical trial NCT05200364 (A Study of STRO-002, an Anti-folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer … Luveltamab tazevibulin, formerly known as STRO-002, is novel homogeneous folate receptor alpha (FolRα) targeting antibody-drug conjugate.

  8. Target

    TIR domain-containing adapter molecule 1

    go.drugbank.com/bio_entities/BE0016552
    TargetHumans

    Involved in innate immunity against invading pathogens. Adapter used by TLR3, TLR4 (through TICAM2) and TLR5 to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis (PubMed:12471095, PubMed:125390...

    Synonyms: Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta
  9. Drug

    Reproterol

    go.drugbank.com/drugs/DB12846
    Investigational

    Reproterol has been used in trials studying the treatment of Asthma, Exercise-Induced.

    Categories: Adrenergics for Systemic Use, Drugs for Obstructive Airway Diseases
  10. Drug

    Diisopromine

    go.drugbank.com/drugs/DB13476
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders, Cytochrome P-450 Substrates